English | 繁體

Search in the results

UM

Browse/Search Results:  1-3 of 3 Help

Selected(0)Clear Items/Page:    Sort:
Pollen allergens sensitization characteristics and risk factors among allergy rhinitis of children in mainland China: A multicenter study Journal article
Luo, Wenting, Li, Yusi, Xu, Lina, Yu, Yongmei, Ma, Jinhai, Wang, Yu, Wang, Yi, Wu, Huajie, Xv, Meng, Wu, Liting, Zhang, Teng, Zheng, Jingping, Hao, Chuangli, Sun, Baoqing. Pollen allergens sensitization characteristics and risk factors among allergy rhinitis of children in mainland China: A multicenter study[J]. Heliyon, 2023, 9(4), e14914.
Authors:  Luo, Wenting;  Li, Yusi;  Xu, Lina;  Yu, Yongmei;  Ma, Jinhai; et al.
Favorite | TC[WOS]:2 TC[Scopus]:2  IF:3.4/3.9 | Submit date：2023/05/02
Allergic Rhinitis  Pollen Allergens Sensitization  Risk Factors  
An open-label randomised comparison of aripiprazole, olanzapine and risperidone for the acute treatment of first-episode schizophrenia: Eight-week outcomes Journal article
Zhang Cheng, Yanbo Yuan, Xue Han, Shangli Cai, Fude Yang, Zheng Lu, Chuanyue Wang, Hong Deng, Jingping Zhao, Yutao Xiang, Christoph U Correll, Xin Yu. An open-label randomised comparison of aripiprazole, olanzapine and risperidone for the acute treatment of first-episode schizophrenia: Eight-week outcomes[J]. JOURNAL OF PSYCHOPHARMACOLOGY, 2019, 33(10), 1227-1236.
Authors:  Zhang Cheng;  Yanbo Yuan;  Xue Han;  Shangli Cai;  Fude Yang; et al.
Favorite | TC[WOS]:28 TC[Scopus]:28  IF:4.5/4.5 | Submit date：2020/05/26
First-episode  Schizophrenia  Antipsychotic  Efficacy  Safety  
Rates and predictors of one-year antipsychotic treatment discontinuation in first-episode schizophrenia: Results from an open-label, randomized, "real world" clinical trial Journal article
Cheng Zhang, Yuan Yanbo, Han Xue, Yang Lei, Zeng Xin, Yang Fude, Lu Zheng, Wang Chuanyue, Deng Hong, Zhao Jingping, Xiang Yu-Tao, Christoph U. Correll, Yu Xin. Rates and predictors of one-year antipsychotic treatment discontinuation in first-episode schizophrenia: Results from an open-label, randomized, "real world" clinical trial[J]. Psychiatry Research, 2019, 273, 631-640.
Authors:  Cheng Zhang;  Yuan Yanbo;  Han Xue;  Yang Lei;  Zeng Xin; et al.
Favorite | TC[WOS]:12 TC[Scopus]:10  IF:4.2/5.3 | Submit date：2020/09/25
First-episode  Antipsychotic  Discontinuation  Predictors  Schizophrenia